Alligator Bioscience AB
556597-8201ActiveClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Oversikt
- 10–19
- Ansatte
- 50–100mill SEK
- Omsetning
- 2000
- Grunnlagt
Nøkkelbeslutningstakere
Karin Nordbladh
Employee representative Board member
Johan Giléus
CFO
Denise Goode
Board member
Hans-Peter Ostler
Chairman of the Board
+3 flere kontakter i Funnelfeedr
Beskrivelse
Alligator Bioscience is a clinical-stage biotechnology company headquartered in Lund, Sweden. The organization focuses on developing innovative antibody-based pharmaceuticals specifically designed for cancer treatment. Their core expertise lies in creating tumor-directed immunotherapies, particularl...
Tagger
Nøkkelord
Bedriftsinformasjon
- Bransje
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556597820101
Beslutningstakere
7 kontakter i FunnelfeedrKarin Nordbladh
Employee representative Board member
Johan Giléus
CFO
Denise Goode
Board member
Hans-Peter Ostler
Chairman of the Board
Søren Bregenholt
CEO
Eva Sjökvist Saers
Board member
David Harrison
Head of Business Development
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrBioInvent International Aktiebolag
100–199 ansatteClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
BIOINVENT FINANS AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
BIOINVENT INTERNATIONAL AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
BIOINVENT INTERNATIONAL AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
CANTARGIA AB
20–49 ansatteDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Utforsk mer
Spørsmål om Alligator Bioscience AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo